Duloxetine for Treatment of Painful Temporomandibular Joint Disorder.
Phase of Trial: Phase IV
Latest Information Update: 15 Apr 2018
At a glance
- Drugs Duloxetine (Primary)
- Indications Facial pain; Musculoskeletal pain
- Focus Therapeutic Use
- 26 Jun 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov.
- 26 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2009 New trial record